David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$410M |
| 2 |
Chevron
CVX
|
+$400M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$381M |
| 4 |
Williams Companies
WMB
|
+$300M |
| 5 |
SLB Ltd
SLB
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$358M |
| 3 |
Biogen
BIIB
|
+$306M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$298M |
| 5 |
Bausch Health
BHC
|
+$298M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 11.89% |
| 2 | Technology | 10.04% |
| 3 | Healthcare | 9.38% |
| 4 | Consumer Discretionary | 8.99% |
| 5 | Industrials | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Sinclair Inc
SBGI
$1.06B
| $9.21M | 0.01% |
329,894
+162,128
| +97% | +$4.89M |
|
1052
PUT
Cardinal Health
CAH
$55.3B
| $9.2M | 0.01% |
110,000
| – | – |
|
1053
Equifax
EFX
$22.5B
| $9.2M | 0.01% |
94,763
-10,063
| -10% | -$982K |
|
1054
AGNC Investment
AGNC
$12.9B
| $9.19M | 0.01% |
+500,000
| New | +$10.3M |
|
1055
Nomura Holdings
NMR
$29B
| $9.16M | 0.01% |
1,354,959
-238,089
| -15% | -$1.55M |
|
1056
Cameco
CCJ
$46.6B
| $9.14M | 0.01% |
639,978
-405,625
| -39% | -$6.4M |
|
|
BRSL
1057
Brightstar Lottery PLC
BRSL
$2.12B
| $9.12M | 0.01% |
513,227
-4,290,889
| -89% | -$81.8M |
|
1058
CALL
Petrobras
PBR
$115B
| $9.1M | 0.01% |
1,005,100
-1,176,800
| -54% | -$10.5M |
|
1059
TransUnion
TRU
$16.3B
| $9.09M | 0.01% |
+362,000
| New | +$9.02M |
|
1060
CALL
Dillards
DDS
$9.95B
| $9.08M | 0.01% |
86,300
+10,000
| +13% | +$1.23M |
|
1061
CALL
NextEra Energy
NEE
$176B
| $9.07M | 0.01% |
370,000
-40,000
| -10% | -$1.02M |
|
1062
Ares Capital
ARCC
$14.3B
| $9.05M | 0.01% |
550,121
-330,686
| -38% | -$5.52M |
|
|
SCTY
1063
CALL
DELISTED
SolarCity Corporation
SCTY
| $9.05M | 0.01% |
169,100
+16,900
| +11% | +$984K |
|
1064
CALL
Diamondback Energy
FANG
$56B
| $9.05M | 0.01% |
120,000
| – | – |
|
1065
Merit Medical Systems
MMSI
$5.44B
| $9.03M | 0.01% |
419,222
+214,093
| +104% | +$4.35M |
|
1066
Cisco
CSCO
$438B
| $9.02M | 0.01% |
328,486
-785,558
| -71% | -$22.5M |
|
1067
PUT
Humana
HUM
$46.8B
| $8.99M | 0.01% |
47,000
+19,200
| +69% | +$3.56M |
|
1068
CALL
Pfizer
PFE
$163B
| $8.98M | 0.01% |
282,261
-232,302
| -45% | -$7.57M |
|
|
SIAL
1069
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $8.96M | 0.01% |
64,278
-142,879
| -69% | -$19.8M |
|
1070
PUT
Ovintiv
OVV
$17.8B
| $8.95M | 0.01% |
162,400
+84,020
| +107% | +$5.34M |
|
1071
Tronox
TROX
$880M
| $8.93M | 0.01% |
610,286
+292,213
| +92% | +$5.5M |
|
1072
Northern Trust
NTRS
$34.2B
| $8.91M | 0.01% |
116,563
-26,200
| -18% | -$1.95M |
|
|
ALXN
1073
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
| $8.91M | 0.01% |
49,300
| – | – |
|
|
ROSE
1074
DELISTED
ROSETTA RESOURCES INC
ROSE
| $8.91M | 0.01% |
384,995
+58,184
| +18% | +$1.33M |
|
1075
Guidewire Software
GWRE
$15.7B
| $8.88M | 0.01% |
167,851
+69,472
| +71% | +$3.58M |
|
Similar funds
David Shaw's Q2 2015 Portfolio in Review
As of Q2 2015, David Shaw held 4,083 positions worth $67.1B, up 2.8% from $65.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw's Q2 2015 filing shows 504 new, 1,541 increased, 1,229 reduced and 364 closed positions. Its largest new stake was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $479M.
By sector, the portfolio is most concentrated in Energy at 12% of assets, up from 10% a quarter earlier, followed by Technology and Healthcare.
- David Shaw's largest Q2 2015 buy was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M.
- David Shaw added most to Gilead Sciences in Q2 2015, an estimated $410M increase.
- David Shaw's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $479M.
- David Shaw fully exited TRW AUTOMOTIVE HOLDINGS CORP in Q2 2015, selling an estimated $164M.
- David Shaw's ten largest holdings make up 11% of its $67.1B portfolio in Q2 2015.
- David Shaw opened 504 new positions and closed 364 in Q2 2015.
- David Shaw's portfolio value rose 2.8% quarter-over-quarter to $67.1B.
Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.